Cargando…

Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks

The prediction of antidepressant response is critical for psychiatrists to select the initial antidepressant drug for patients with major depressive disorders (MDD). The implicated brain networks supporting emotion regulation (ER) are critical in the pathophysiology of MDD and the prediction of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hang, Liu, Rui, Zhou, Jingjing, Feng, Lei, Wang, Yun, Chen, Xiongying, Zhang, Zhifang, Cui, Jian, Zhou, Yuan, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482642/
https://www.ncbi.nlm.nih.gov/pubmed/36115833
http://dx.doi.org/10.1038/s41398-022-02152-0
_version_ 1784791499551014912
author Wu, Hang
Liu, Rui
Zhou, Jingjing
Feng, Lei
Wang, Yun
Chen, Xiongying
Zhang, Zhifang
Cui, Jian
Zhou, Yuan
Wang, Gang
author_facet Wu, Hang
Liu, Rui
Zhou, Jingjing
Feng, Lei
Wang, Yun
Chen, Xiongying
Zhang, Zhifang
Cui, Jian
Zhou, Yuan
Wang, Gang
author_sort Wu, Hang
collection PubMed
description The prediction of antidepressant response is critical for psychiatrists to select the initial antidepressant drug for patients with major depressive disorders (MDD). The implicated brain networks supporting emotion regulation (ER) are critical in the pathophysiology of MDD and the prediction of antidepressant response. Therefore, the primary aim of the current study was to identify the neuroimaging biomarkers for the prediction of remission in patients with MDD based on the resting-state functional connectivity (rsFC) of the ER networks. A total of 81 unmedicated adult MDD patients were investigated and they underwent resting-state functional magnetic resonance imagining (fMRI) scans. The patients were treated with escitalopram for 12 weeks. The 17-item Hamilton depression rating scale was used for assessing remission. The 36 seed regions from predefined ER networks were selected and the rsFC matrix was caculated for each participant. The support vector machine algorithm was employed to construct prediction model, which separated the patients with remission from those with non-remission. And leave-one-out cross-validation and the area under the curve (AUC) of the receiver operating characteristic were used for evaluating the performance of the model. The accuracy of the prediction model was 82.08% (sensitivity = 71.43%, specificity = 89.74%, AUC = 0.86). The rsFC between the left medial superior frontal gyrus and the right inferior frontal gyrus as well as the precuneus were the features with the highest discrimination ability in predicting remission from escitalopram among the MDD patients. Results from our study demonstrated that rsFC of the ER brain networks are potential predictors for the response of antidepressant drugs. The trial name: appropriate technology study of MDD diagnosis and treatment based on objective indicators and measurement. URL: http://www.chictr.org.cn/showproj.aspx?proj=21377. Registration number: ChiCTR-OOC-17012566.
format Online
Article
Text
id pubmed-9482642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94826422022-09-19 Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks Wu, Hang Liu, Rui Zhou, Jingjing Feng, Lei Wang, Yun Chen, Xiongying Zhang, Zhifang Cui, Jian Zhou, Yuan Wang, Gang Transl Psychiatry Article The prediction of antidepressant response is critical for psychiatrists to select the initial antidepressant drug for patients with major depressive disorders (MDD). The implicated brain networks supporting emotion regulation (ER) are critical in the pathophysiology of MDD and the prediction of antidepressant response. Therefore, the primary aim of the current study was to identify the neuroimaging biomarkers for the prediction of remission in patients with MDD based on the resting-state functional connectivity (rsFC) of the ER networks. A total of 81 unmedicated adult MDD patients were investigated and they underwent resting-state functional magnetic resonance imagining (fMRI) scans. The patients were treated with escitalopram for 12 weeks. The 17-item Hamilton depression rating scale was used for assessing remission. The 36 seed regions from predefined ER networks were selected and the rsFC matrix was caculated for each participant. The support vector machine algorithm was employed to construct prediction model, which separated the patients with remission from those with non-remission. And leave-one-out cross-validation and the area under the curve (AUC) of the receiver operating characteristic were used for evaluating the performance of the model. The accuracy of the prediction model was 82.08% (sensitivity = 71.43%, specificity = 89.74%, AUC = 0.86). The rsFC between the left medial superior frontal gyrus and the right inferior frontal gyrus as well as the precuneus were the features with the highest discrimination ability in predicting remission from escitalopram among the MDD patients. Results from our study demonstrated that rsFC of the ER brain networks are potential predictors for the response of antidepressant drugs. The trial name: appropriate technology study of MDD diagnosis and treatment based on objective indicators and measurement. URL: http://www.chictr.org.cn/showproj.aspx?proj=21377. Registration number: ChiCTR-OOC-17012566. Nature Publishing Group UK 2022-09-17 /pmc/articles/PMC9482642/ /pubmed/36115833 http://dx.doi.org/10.1038/s41398-022-02152-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wu, Hang
Liu, Rui
Zhou, Jingjing
Feng, Lei
Wang, Yun
Chen, Xiongying
Zhang, Zhifang
Cui, Jian
Zhou, Yuan
Wang, Gang
Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title_full Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title_fullStr Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title_full_unstemmed Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title_short Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
title_sort prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482642/
https://www.ncbi.nlm.nih.gov/pubmed/36115833
http://dx.doi.org/10.1038/s41398-022-02152-0
work_keys_str_mv AT wuhang predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT liurui predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT zhoujingjing predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT fenglei predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT wangyun predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT chenxiongying predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT zhangzhifang predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT cuijian predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT zhouyuan predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks
AT wanggang predictionofremissionamongpatientswithamajordepressivedisorderbasedontherestingstatefunctionalconnectivityofemotionregulationnetworks